Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Adjust height of sidebar
KMap
Grants
Scroll left
Active Only
Funding Agencies
Scroll right
Grants
(14292)
A Phase 3, Open-Label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 X Anti-CD3 BiSpecific Antibody, Versus Investigator's Choice in Previously Untreated
Sponsored by For Profit
·
3
·
2024
·
$7.5M
·
External
immunotherapy,
cancer treatment,
biopharmaceuticals,
clinical trials,
monoclonal antibodies
Arizona Transportation Institute
Sponsored by Through Arizona
·
1
·
2024
·
$5.2M
·
External
transportation,
arizona,
institute,
research,
engineering
NRT-HDR: CAMBIUM - Climate change Adaptation and Mitigation through Biodiversity Informatics edUcation and Mentoring
Sponsored by National Science Foundation NSF
·
11
·
2024
·
$3M
·
External
climate change,
biodiversity,
adaptation,
mitigation,
informatics
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure (DRAIN-HF)
Sponsored by For Profit
·
1
·
2024
·
$2.9M
·
External
heart failure,
diuretics,
aortix endovascular device,
cardiovascular intervention,
acute treatment
Arizona Pediatric Psychiatry Access Line
Sponsored by Through Arizona
·
1
·
2024
·
$2M
·
External
pediatric psychiatry,
mental health,
telemedicine,
childhood development,
healthcare access
Expanding AD Biomarkers in NIA funded PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Tria
Sponsored by Other Non-Profit Sponsors
·
4
·
2024
·
$1.8M
·
External
biomarkers,
menopause,
brain metabolism,
cognition,
clinical trial
A Dose-Escalation and Expansion Study of the Safety and Pharmacokinetics of XB002 As Single-Agent And Combination Therapy In Subjects With Inoperable Locally Advanced or Metastatic Solid Tumors
Sponsored by For Profit
·
7
·
2024
·
$1.6M
·
External
cancer,
pharmacokinetics,
drug therapy,
clinical trial,
tumor treatment
Disrupted Lipid Metabolism in Alzheimer's Disease
Sponsored by Department of Health and Human Services HHS
·
5
·
2024
·
$1.6M
·
External
alzheimer's disease,
lipid metabolism,
brain health,
neurodegeneration,
metabolic disorders
AccelNet Implementation Phase 1: Tools for Addressing Cultural, Ethical, Legal, and Social Implications of the CARE Principles for Research Data Ecosystems
Sponsored by National Science Foundation NSF
·
3
·
2024
·
$1.5M
·
External
ethical considerations,
cultural implications,
legal frameworks,
research data governance,
social impact
Quantum Bayesian Estimation and Applications to Magnetometry
Sponsored by Department of Army DA
·
5
·
2024
·
$1.4M
·
External
quantum computing,
bayesian statistics,
magnetometry,
quantum information,
estimation theory
Arizona Transportation Institute
Sponsored by State Govt-Arizona
·
1
·
2024
·
$1.3M
·
External
transportation,
arizona,
institute,
research,
technology
CyberCorps Scholarship for Service (Renewal): The AZSecure Program Empowering Cybersecurity through Artificial Intelligence
Sponsored by National Science Foundation NSF
·
6
·
2024
·
$1.3M
·
External
cybersecurity,
artificial intelligence,
scholarship,
renewal,
empowerment
A Phase 3 Randomized Clinical Study of MK-4280A (coformulated favezelimab (MK-4280) plus pembrolizumab (MK-3475)) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory C
Sponsored by For Profit
·
2
·
2024
·
$1.3M
·
External
immunotherapy,
cancer treatment,
clinical trial,
pd-(l)1 inhibitors,
combination therapy
An Agile Multi-Frequency VLBI Receiver for the South Pole Telescope
Sponsored by National Science Foundation NSF
·
2
·
2024
·
$1.3M
·
External
radio astronomy,
instrumentation,
telescope technology,
signal processing,
observational astronomy
Hypothalamic Regulation by Thyroid Hormone Receptor Phosphorylation
Sponsored by Department of Health and Human Services HHS
·
1
·
2024
·
$1.3M
·
External
hypothalamus regulation,
thyroid hormone,
receptor phosphorylation,
endocrine regulation,
cell signaling
A Phase 3, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Compared to R2 in Subjects with Relapsed or Refractory Follicular Lymphom
Sponsored by For Profit
·
3
·
2024
·
$1.2M
·
External
lymphoma,
efficacy,
safety,
treatment,
clinical trial
A Phase I/II, Randomized, Double-blind, Sham Control Study to Explore Safety, Tolerability, and Efficacy Signals of Multiple Ascending Doses of Striatally-Administered rAAV5-miHTT Total Huntingtin Gen
Sponsored by Foreign For Profit
·
1
·
2024
·
$1.1M
·
External
gene therapy,
neurodegenerative diseases,
clinical trial,
genetic disorders,
drug safety
Glycerol Regulation of Gluconeogenesis and Fatty Acid Metabolism
Sponsored by Department of Health and Human Services HHS
·
4
·
2024
·
$1.1M
·
External
gluconeogenesis,
fatty acid metabolism,
glycerol regulation
Supporting Communities and Small Business by Conducting Risk and Vulnerability Assessments through Student Experiential Learning Opportunities
Sponsored by For Profit
·
4
·
2024
·
$1M
·
External
community support,
small business,
risk assessment,
vulnerability assessment,
experiential learning
UArizona / Faculty Organizing for Community Archives Support (FOCAS) Internship & Resource Development Project
Sponsored by Other Non-Profit Sponsors
·
2
·
2024
·
$1M
·
External
community archives,
internship,
resource development,
faculty organizing,
support
Page 1 of 715
Previous page
Next page
